Shukra Pharmaceuticals Allots 1.17M Equity Shares Upon Warrant Conversion to Promoters
Shukra Pharmaceuticals Ltd 路 Others (Uncategorized) 路 03 Sept 2026, 12:19 am
Shukra Pharmaceuticals Allots 1.17M Equity Shares Upon Warrant Conversion to Promoters On 2nd Sep'26, Shukra Pharmaceuticals allotted 11,73,000 equity shares to promoter Navkar Surgical Gujarat Ltd upon warrant conversion. This follows the receipt of the balance 75% exercise price of Rs.26.67 per share, generating Rs.3.13 crore. Consequently, paid-up equity capital increased to Rs.44.08 crore, with Navkar Surgical's post-issue stake rising to 11.93%. Following this tranche, 17,35,000 warrants from the 28th Jan'26 issuance remain outstanding, convertible upon payment of the remaining 75% premium within the 18-month validity period.
Original exchange filing (PDF)
More announcements from Shukra Pharmaceuticals Ltd
- Approval for Change of Name of Company on National Stock Exchange Limited dated 16th November 2026 路 17 Nov 2026
- Media Release 路 05 Nov 2026
- Shukra Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Reg 32 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- SHUKRA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 04 Nov 2026
- The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 路 04 Nov 2026
